Laserfiche WebLink
HF100 NINTH ENGROSSMENT REVISOR BD 1-10100-9 <br />269.1 (4) n-hydroxy-methylenedioxyamphetamine; <br />269.2 (5) 4-bromo-2,5-dimethoxyamphetamine (DOB); <br />269.3 (6) 2,5-dimethoxyamphetamine (2,5-DMA); <br />269.4 (7) 4-methoxyamphetamine; <br />269.5 (8) 5-methoxy-3, 4-methylenedioxyamphetamine; <br />269.6 (9) alpha-ethyltryptamine; <br />269.7 (10) bufotenine; <br />269.8 (11) diethyltryptamine; <br />269.9 (12) dimethyltryptamine; <br />269.10 (13) 3,4,5-trimethoxyamphetamine; <br />269.11 (14) 4-methyl-2, 5-dimethoxyamphetamine (DOM); <br />269.12 (15) ibogaine; <br />269.13 (16) lysergic acid diethylamide (LSD); <br />269.14 (17) mescaline; <br />269.15 (18) parahexyl; <br />269.16 (19) N- ethyl- 3 -piperidyl benzilate; <br />269.17 (20) N-methyl-3-piperidyl benzilate; <br />269.18 (21) psilocybin; <br />269.19 (22) psilocyn; <br />269.20 (23) tenocyclidine (TPCP or TCP); <br />269.21 (24) N-ethyl- I -phenyl-cyclohexylamine (PCE); <br />269.22 (25) 1 -(1 -phenylcyclohexyl) pyrrolidine (PCPy); <br />269.23 (26) 1-[I-(2-thienyl)cyclohexyl]-pyrrolidine (TCPy); <br />269.24 (27) 4-chloro-2,5-dimethoxyamphetamine (DOC); <br />269.25 (28) 4-ethyl-2,5-dimethoxyamphetamine (DOET); <br />269.26 (29) 4-iodo-2,5-dimethoxyamphetamine (DOI); <br />269.27 (30) 4-bromo-2,5-dimethoxyphenethylamine (2C-B); <br />Article 8 Section 1. 269 <br />